Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichiro Shibata

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Molecular and Cellular Biology|November 8, 2006
The RNA polymerase II kinase Ctk1 regulates positioning of a 5' histone methylation boundary along genesTiaojiang Xiao, Yoichiro Shibata, Bhargavi Rao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2007
CCR4/NOT complex associates with the proteasome and regulates histone methylationR Nicholas Laribee, Yoichiro Shibata, Douglas P Mersman, et al.
Genome Biology|October 5, 2012
Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificityAlok K Tewari, Galip Gürkan Yardimci, Yoichiro Shibata, et al.
Scientific Reports|September 28, 2016
Microgravity induces proteomics changes involved in endoplasmic reticulum stress and mitochondrial protectionBryan J Feger, J Will Thompson, Laura G Dubois, et al.
Cancer Research Communications|March 16, 2023
Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal CancerJoel R Eisner, Kirk D Beebe, Gregory M Mayhew, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont StudyJoel R Eisner, Gregory M Mayhew, James M Davison, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2024
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based ImmunotherapiesKirk D Beebe, Joel R Eisner, John Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2024
Characterization of FGFR Alterations and Activation in Patients with High-Risk Non-Muscle-Invasive Bladder CancerJoel R Eisner, Florus C de Jong, Yoichiro Shibata, et al.
Plos Genetics|July 5, 2012
Extensive evolutionary changes in regulatory element activity during human origins are associated with altered gene expression and positive selectionYoichiro Shibata, Nathan C Sheffield, Olivier Fedrigo, et al.
British Journal of Cancer|March 12, 2022
Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experienceTracy L Rose, William H Weir, Gregory M Mayhew, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Molecular and Cellular Biology|November 8, 2006
The RNA polymerase II kinase Ctk1 regulates positioning of a 5' histone methylation boundary along genesTiaojiang Xiao, Yoichiro Shibata, Bhargavi Rao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2007
CCR4/NOT complex associates with the proteasome and regulates histone methylationR Nicholas Laribee, Yoichiro Shibata, Douglas P Mersman, et al.
Genome Biology|October 5, 2012
Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificityAlok K Tewari, Galip Gürkan Yardimci, Yoichiro Shibata, et al.
Scientific Reports|September 28, 2016
Microgravity induces proteomics changes involved in endoplasmic reticulum stress and mitochondrial protectionBryan J Feger, J Will Thompson, Laura G Dubois, et al.
Cancer Research Communications|March 16, 2023
Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal CancerJoel R Eisner, Kirk D Beebe, Gregory M Mayhew, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non-Small Cell Lung Cancer: The Piedmont StudyJoel R Eisner, Gregory M Mayhew, James M Davison, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 20, 2024
The Immunogenomic Landscape of Peripheral High-Dose IL-2 Pharmacodynamics in Patients with Metastatic Renal Cell Carcinoma: A Benchmark for Next-Generation IL-2-Based ImmunotherapiesKirk D Beebe, Joel R Eisner, John Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2024
Characterization of FGFR Alterations and Activation in Patients with High-Risk Non-Muscle-Invasive Bladder CancerJoel R Eisner, Florus C de Jong, Yoichiro Shibata, et al.
Plos Genetics|July 5, 2012
Extensive evolutionary changes in regulatory element activity during human origins are associated with altered gene expression and positive selectionYoichiro Shibata, Nathan C Sheffield, Olivier Fedrigo, et al.
British Journal of Cancer|March 12, 2022
Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experienceTracy L Rose, William H Weir, Gregory M Mayhew, et al.
Pageof 4